We are live on ! Find out more
INSM icon

Insmed
INSM

202 hedge funds and large institutions have $3.42B invested in Insmed in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 89 increasing their positions, 51 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 51

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

25% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 24

21% more call options, than puts

Call options by funds: $4.04M | Put options by funds: $3.33M

3.59% more ownership

Funds ownership: 103.46% → 107.05% (+3.6%)

2% more funds holding

Funds holding: 198 → 202 (+4)

6% less capital invested

Capital invested by funds: $3.63B → $3.42B (-$209M)

Holders
202
Holders Change
+4
Holders Change %
+2.02%
% of All Funds
3.52%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
30
Increased
89
Reduced
51
Closed
24
Calls
$4.04M
Puts
$3.33M
Net Calls
+$707K
Net Calls Change
+$474K

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$91.1M
2
Macquarie Group
Macquarie Group
Australia
+$86.9M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
+$60.3M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$51.4M
5
William Blair Investment Management
William Blair Investment Management
Illinois
+$37.5M

Top Sellers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$62.3M
2
Artisan Partners
Artisan Partners
Wisconsin
-$60.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$48.5M
4
Invesco
Invesco
Georgia
-$16.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$409M +$91.1M +3,070,140 +27%
Vanguard Group
2
Vanguard Group
Pennsylvania
$303M +$28.5M +961,181 +10%
BlackRock
3
BlackRock
New York
$246M +$8.35M +281,423 +3%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$226M +$51.4M +1,733,425 +28%
PAI
5
Palo Alto Investors
California
$171M +$5.78M +194,599 +3%
William Blair Investment Management
6
William Blair Investment Management
Illinois
$143M +$37.5M +1,261,948 +34%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$123M -$48.5M -1,634,550 -27%
Ameriprise
8
Ameriprise
Minnesota
$116M +$20.3M +682,954 +20%
State Street
9
State Street
Massachusetts
$102M +$10.2M +344,203 +11%
Franklin Resources
10
Franklin Resources
California
$98.2M +$18.2M +614,197 +22%
Macquarie Group
11
Macquarie Group
Australia
$90.8M +$86.9M +2,927,018 +1,115%
BG
12
Bellevue Group
Switzerland
$88.8M +$19.1M +643,735 +26%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$81.8M -$48.3K -1,626 -0.1%
PAMU
14
Pictet Asset Management (UK)
United Kingdom
$72.7M +$60.3M +2,032,553 +390%
Holocene Advisors
15
Holocene Advisors
New York
$71.2M +$21.5M +723,666 +41%
BBA
16
Baker Bros. Advisors
New York
$61.4M – – –
AllianceBernstein
17
AllianceBernstein
Tennessee
$58.2M +$6.71M +226,113 +12%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$54M +$5.2M +175,316 +10%
FLAM
19
First Light Asset Management
Minnesota
$39.4M +$12.9M +434,695 +46%
FFM
20
Fairmount Funds Management
Pennsylvania
$36.5M +$9.56M +322,090 +33%
SC
21
Samlyn Capital
New York
$34.5M +$19.4M +652,579 +117%
Northern Trust
22
Northern Trust
Illinois
$32.8M +$1.06M +35,620 +3%
APM
23
Avidity Partners Management
Texas
$32.7M +$34.1M +1,150,050 New
Norges Bank
24
Norges Bank
Norway
$31.5M +$1.66M +55,780 +5%
EAM
25
Eagle Asset Management
Florida
$29.4M +$451K +15,182 +1%
1
2 3 4 5

INSM Hedge Fund Activity: Q2 2021 in Review

202 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2021, worth a combined $3.42B — down 5.8% from $3.63B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new INSM positions and 24 closed out — a net gain of 6 holders — while 89 added to existing stakes and 51 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $91.1M. The largest seller was Lord, Abbett & Co, cutting an estimated $62.3M.

  • 202 institutional investors held Insmed (INSM) as of Q2 2021, up from 198 in Q1 2021.
  • Funds reported $3.42B of Insmed stock for Q2 2021, down 5.8% quarter-over-quarter.
  • 30 funds opened new Insmed positions in Q2 2021 and 24 closed out, a net change of +6 holders.
  • The largest Insmed buyer in Q2 2021 was T. Rowe Price Associates, an estimated $91.1M added.
  • The largest Insmed seller in Q2 2021 was Lord, Abbett & Co, an estimated $62.3M sold.

Based on aggregated 13F filings for Q2 2021.